HOWL FY 2023 Earnings — Werewolf Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HOWLWerewolf Therapeutics, Inc.

$35M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$20M+21.6% YoY

Gross Profit

$18M91.2% margin

Operating Income

-$41M-203.1% margin

Net Income

-$37M-187.4% margin

EPS (Diluted)

$-1.05

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$33M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$175M

Total Liabilities

$63M

Stockholders' Equity

$111M

Cash & Equivalents

$134M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$16M	+21.6%
Gross Profit	$18M	$14M	+30.9%
Operating Income	-$41M	-$56M	+27.7%
Net Income	-$37M	-$54M	+30.6%